Ausgabe 1/2014
Inhalt (26 Artikel)
Breast cancer and aging: results of the U13 conference breast cancer panel
M. F. Barginear, H. Muss, G. Kimmick, C. Owusu, E. Mrozek, A. Shahrokni, K. Ballman, A. Hurria
A retrospective study evaluating a fixed low dose capecitabine monotherapy in women with HER-2 negative metastatic breast cancer
Tadeu Ambros, Simon B. Zeichner, John Zaravinos, Alberto J. Montero, Eugene Ahn, Mani Aruna, Lori Kronish, Reshma L. Mahtani, Charles L. Vogel
Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer
S. Muenst, A. R. Schaerli, F. Gao, S. Däster, E. Trella, R. A. Droeser, M. G. Muraro, P. Zajac, R. Zanetti, W. E. Gillanders, W. P. Weber, S. D. Soysal
Hypomethylation of the MMP7 promoter and increased expression of MMP7 distinguishes the basal-like breast cancer subtype from other triple-negative tumors
Steven T. Sizemore, Gina M. Sizemore, Christine N. Booth, Cheryl L. Thompson, Paula Silverman, Gurkan Bebek, Fadi W. Abdul-Karim, Stefanie Avril, Ruth A. Keri
The metastatic potential of triple-negative breast cancer is decreased via caloric restriction-mediated reduction of the miR-17~92 cluster
Lianjin Jin, Meng Lim, Shuping Zhao, Yuri Sano, Brittany A. Simone, Jason E. Savage, Eric Wickstrom, Kevin Camphausen, Richard G. Pestell, Nicole L. Simone
Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071
Yayun Liang, Cynthia Besch-Williford, Johannes D. Aebi, Benford Mafuvadze, Matthew T. Cook, Xiaoqin Zou, Salman M. Hyder
A multi-institutional study on the association between BRCA1/BRCA2 mutational status and triple-negative breast cancer in familial breast cancer patients
Moon-Woo Seong, Kyu Hyung Kim, Il Yong Chung, Eunyoung Kang, Jong Won Lee, Sue K. Park, Min Hyuk Lee, Jeong Eon Lee, Dong-Young Noh, Byung Ho Son, Hai-Lin Park, Sung Im Cho, Sung Sup Park, Sung-Won Kim
Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells
Chun-Yu Liu, Jung-Chen Su, Mei-Huei Ni, Ling-Ming Tseng, Pei-Yi Chu, Duen-Shian Wang, Wei-Tien Tai, Yuan-Ping Kao, Man-Hsin Hung, Chung-Wai Shiau, Kuen-Feng Chen
HITS-CLIP reveals key regulators of nuclear receptor signaling in breast cancer
Manoj M. Pillai, Austin E. Gillen, Tomomi M. Yamamoto, Enos Kline, Joseph Brown, Kale Flory, Jay R. Hesselberth, Peter Kabos
Inhibition of histone demethylase, LSD2 (KDM1B), attenuates DNA methylation and increases sensitivity to DNMT inhibitor-induced apoptosis in breast cancer cells
Tiffany A. Katz, Shauna N. Vasilatos, Emily Harrington, Steffi Oesterreich, Nancy E. Davidson, Yi Huang
A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI
A. Lintermans, K. Van Asten, H. Wildiers, A. Laenen, R. Paridaens, C. Weltens, J. Verhaeghe, D. Vanderschueren, A. Smeets, E. Van Limbergen, K. Leunen, M. R. Christiaens, P. Neven
Quality of life and patient satisfaction after microsurgical abdominal flap versus staged expander/implant breast reconstruction: a critical study of unilateral immediate breast reconstruction using patient-reported outcomes instrument BREAST-Q
Chunjun Liu, Yan Zhuang, Arash Momeni, Jie Luan, Michael T. Chung, Eric Wright, Gordon K. Lee
Early myocardial deformation abnormalities in breast cancer survivors
Ben F. Bulten, Annelies M. C. Mavinkurve-Groothuis, Lioe-Fee de Geus-Oei, Anton F. J. de Haan, Chris L. de Korte, Louise Bellersen, Hanneke W. M. van Laarhoven, Livia Kapusta
Use of dried blood spots for the determination of serum concentrations of tamoxifen and endoxifen
N. G. L. Jager, H. Rosing, J. H. M. Schellens, J. H. Beijnen, S. C. Linn
A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer
Yifan Tu, Dawn L. Hershman, Kapil Bhalla, Warren Fiskus, Christine M. Pellegrino, Eleni Andreopoulou, Della Makower, Kevin Kalinsky, Karen Fehn, Susan Fineberg, Abdissa Negassa, Leslie L. Montgomery, Lisa S. Wiechmann, R. Katherine Alpaugh, Min Huang, Joseph A. Sparano
Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study
Mark J. Clemons, Brandy Cochrane, Gregory R. Pond, Nadia Califaretti, Stephen K. L. Chia, Rebecca Alexandra Dent, Xinni Song, Andre Robidoux, Sameer Parpia, David Warr, Daniel Rayson, Kathleen I. Pritchard, Mark N. Levine
Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis
Dharanija Madhavan, Markus Wallwiener, Karin Bents, Manuela Zucknick, Juliane Nees, Sarah Schott, Katarina Cuk, Sabine Riethdorf, Andreas Trumpp, Klaus Pantel, Christof Sohn, Andreas Schneeweiss, Harald Surowy, Barbara Burwinkel
Outcome of triple negative breast cancer: comparison of sporadic and BRCA1-associated cancers
Nadine Tung, Elizabeth Gaughan, Michele R. Hacker, Larissa J. Lee, Brian Alexander, Emily Poles, Stuart J. Schnitt, Judy E. Garber
Overweight and obesity as poor prognostic factors in locally advanced breast cancer patients
C. Arce-Salinas, J. L. Aguilar-Ponce, C. Villarreal-Garza, F. U. Lara-Medina, D. Olvera-Caraza, A. Alvarado Miranda, D. Flores-Díaz, A. Mohar
Body mass index, diabetes, and triple-negative breast cancer prognosis
Sarah Tait, Jose M. Pacheco, Feng Gao, Caroline Bumb, Matthew James Ellis, Cynthia X. Ma
The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer
Susan A. Sabatino, Trevor D. Thompson, Xiao-Cheng Wu, Steven T. Fleming, Gretchen G. Kimmick, Amy Trentham-Dietz, Rosemary Cress, Roger T. Anderson
Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data
Svasti Haricharan, Matthew N. Bainbridge, Paul Scheet, Powel H. Brown
Mortality outcome among medically underserved women screened through a publicly funded breast cancer control program, 1997–2007
Soumitra Sudip Bhuyan, Jim P. Stimpson, Shireen S. Rajaram, Ge Lin
Determining axillary concordance rate for different injection locations in sentinel node mapping of breast cancer: how ambitious can we get?
Ramin Sadeghi, Mehdi Asadi, Giorgio Treglia, Seyed Rasoul Zakavi, Asiehsadat Fattahi, David N. Krag
Erratum to: The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis
Josh J. Carlson, Joshua A. Roth